As the UK experiments with a subscription-style payment system to resuscitate the fledgling antibiotic industry — in the United States, the Centers for Medicare & Medicaid Services (CMS) is working on restructuring the payment apparatus for new antibiotics to revitalize antimicrobial development and rescue existing manufacturers.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,